Stay updated with breaking news from Previously Twitter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Mainz BioMed N.V. / Key word: Study results Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers ...
ColoAlert® Revenue Increases 102% Year Over Year for the Nine Months Ended September 30, 2023ColoFuture Study Reported Groundbreaking Results Demonstrating Sensitivity for Colorectal Cancer of 94%...
Issuer: Mainz BioMed N.V. / Key word: Conference Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA 07.11.2023 / 14:01 CET/CEST The issuer...
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz Biomed Reports Success from Employee Colorectal Cancer Screenin...
BERKELEY, Calif. and MAINZ, Germany, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecu...